Bortezomib Plus Cisplatin in Recurrent or Metastatic Breast Cancer

Clinical trial NCT06900647 · RECRUITING

Trial details

NCT number: NCT06900647
Sponsor: Sun Yat-sen University
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Breast Cancer Recurrent Breast Cancer

Start date: 2025-01-01
Primary completion: 2026-06-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.